Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Dopaminergic striatal innervation predicts interlimb transfer of a visuomotor skill.

Isaias IU, Moisello C, Marotta G, Schiavella M, Canesi M, Perfetti B, Cavallari P, Pezzoli G, Ghilardi MF.

J Neurosci. 2011 Oct 12;31(41):14458-62. doi: 10.1523/JNEUROSCI.3583-11.2011.

2.

Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.

Oh M, Kim JS, Kim JY, Shin KH, Park SH, Kim HO, Moon DH, Oh SJ, Chung SJ, Lee CS.

J Nucl Med. 2012 Mar;53(3):399-406. doi: 10.2967/jnumed.111.095224. Epub 2012 Feb 9.

3.

Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism.

Carbon M, Ma Y, Barnes A, Dhawan V, Chaly T, Ghilardi MF, Eidelberg D.

Neuroimage. 2004 Apr;21(4):1497-507.

PMID:
15050574
4.

Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease.

Siepel FJ, Brønnick KS, Booij J, Ravina BM, Lebedev AV, Pereira JB, Grüner R, Aarsland D.

Mov Disord. 2014 Dec;29(14):1802-8. doi: 10.1002/mds.26051. Epub 2014 Oct 4.

PMID:
25284687
5.

Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.

Iranzo A, Valldeoriola F, Lomeña F, Molinuevo JL, Serradell M, Salamero M, Cot A, Ros D, Pavía J, Santamaria J, Tolosa E.

Lancet Neurol. 2011 Sep;10(9):797-805. doi: 10.1016/S1474-4422(11)70152-1. Epub 2011 Jul 28.

PMID:
21802993
6.

Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.

Seibyl JP, Marek K, Sheff K, Zoghbi S, Baldwin RM, Charney DS, van Dyck CH, Innis RB.

J Nucl Med. 1998 Sep;39(9):1500-8.

7.

The influence of dopaminergic striatal innervation on upper limb locomotor synergies.

Isaias IU, Volkmann J, Marzegan A, Marotta G, Cavallari P, Pezzoli G.

PLoS One. 2012;7(12):e51464. doi: 10.1371/journal.pone.0051464. Epub 2012 Dec 7.

8.

Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients.

Santangelo G, Vitale C, Picillo M, Cuoco S, Moccia M, Pezzella D, Erro R, Longo K, Vicidomini C, Pellecchia MT, Amboni M, Brunetti A, Salvatore M, Barone P, Pappatà S.

Parkinsonism Relat Disord. 2015 May;21(5):489-93. doi: 10.1016/j.parkreldis.2015.02.015. Epub 2015 Feb 25.

PMID:
25753457
9.

Striatal dopamine transporter binding in patients with Parkinson's disease and severe occupational hydrocarbon exposure.

Canesi M, Benti R, Marotta G, Cilia R, Isaias IU, Gerundini P, Pezzoli G, Antonini A.

Eur J Neurol. 2007 Mar;14(3):297-9.

PMID:
17355550
10.

Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients.

Erro R, Pappatà S, Amboni M, Vicidomini C, Longo K, Santangelo G, Picillo M, Vitale C, Moccia M, Giordano F, Brunetti A, Pellecchia MT, Salvatore M, Barone P.

Parkinsonism Relat Disord. 2012 Nov;18(9):1034-8. doi: 10.1016/j.parkreldis.2012.05.022. Epub 2012 Jul 11.

PMID:
22789824
11.

Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.

Tissingh G, Booij J, Bergmans P, Winogrodzka A, Janssen AG, van Royen EA, Stoof JC, Wolters EC.

J Nucl Med. 1998 Jul;39(7):1143-8.

12.

[99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease.

Siderowf A, Newberg A, Chou KL, Lloyd M, Colcher A, Hurtig HI, Stern MB, Doty RL, Mozley PD, Wintering N, Duda JE, Weintraub D, Moberg PJ.

Neurology. 2005 May 24;64(10):1716-20.

PMID:
15911797
13.

Striatal dopamine and learning strategy-an (123)I-FP-CIT SPECT study.

Berger HJ, Cools AR, Horstink MW, Oyen WJ, Verhoeven EW, van der Werf SP.

Neuropsychologia. 2004;42(8):1071-8.

PMID:
15093146
14.

Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson's disease.

Rektorova I, Srovnalova H, Kubikova R, Prasek J.

Mov Disord. 2008 Aug 15;23(11):1580-7. doi: 10.1002/mds.22158.

PMID:
18618663
15.

Evaluation of dopaminergic function in frontotemporal dementia using I-FP-CIT single photon emission computed tomography.

Sedaghat F, Gotzamani-Psarrakou A, Dedousi E, Arnaoutoglou M, Psarrakos K, Baloyannis I, Dimitriadis AS, Baloyannis SJ.

Neurodegener Dis. 2007;4(5):382-5. Epub 2007 Jul 6.

PMID:
17622781
16.

Greater striatal dopamine transporter density may be associated with major depressive episode.

Amsterdam JD, Newberg AB, Soeller I, Shults J.

J Affect Disord. 2012 Dec 10;141(2-3):425-31. doi: 10.1016/j.jad.2012.03.007. Epub 2012 Apr 4.

17.

Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison.

Walker Z, Costa DC, Walker RW, Lee L, Livingston G, Jaros E, Perry R, McKeith I, Katona CL.

Neurology. 2004 May 11;62(9):1568-72.

PMID:
15136683
18.

SPECT imaging of dopamine transporters with (99m)Tc-TRODAT-1 in major depression and Parkinson's disease.

Wu H, Lou C, Huang Z, Shi G.

J Neuropsychiatry Clin Neurosci. 2011 Winter;23(1):63-7. doi: 10.1176/appi.neuropsych.23.1.63.

PMID:
21304140
19.

Substantia nigra echogenicity and imaging of striatal dopamine transporters in Parkinson's disease: a cross-sectional study.

Bor-Seng-Shu E, Pedroso JL, Felicio AC, de Andrade DC, Teixeira MJ, Braga-Neto P, Batista IR, Barsottini OG, Borges V, Ferraz HB, Shih MC, Bressan RA, de Andrade LA, Walter U.

Parkinsonism Relat Disord. 2014 May;20(5):477-81. doi: 10.1016/j.parkreldis.2014.01.015. Epub 2014 Feb 6.

PMID:
24629800
20.

Supplemental Content

Support Center